Empirical treatment of fever in neutropenic children: The role of the carbapenems

被引：10

作者：

Cometta, A ^{[1
]}

Viscoli, C ^{[1
]}

Castagnola, E ^{[1
]}

Massimo, L ^{[1
]}

Giacchino, R ^{[1
]}

Gibson, B ^{[1
]}

Giacchino, M ^{[1
]}

Balbo, L ^{[1
]}

Engelhard, D ^{[1
]}

Shapiro, M ^{[1
]}

Amsallem, D ^{[1
]}

Estavoyer, JM ^{[1
]}

Ferster, A ^{[1
]}

Glauser, MP ^{[1
]}

机构：

[1] CHU VAUDOIS, DIV INFECT DIS, CH-1011 LAUSANNE, SWITZERLAND

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1996年 / 15卷 / 08期

关键词：

neutropenia; carbapenems; imipenem; meropenem;

D O I：

10.1097/00006454-199608000-00036

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：744 / 748

页数：5

共 50 条

[31] Investigation of infection in the neutropenic patient with fever
Gillespie, T
Masterton, RG
JOURNAL OF HOSPITAL INFECTION, 1998, 38 (02) : 77 - 91
[32] IMIPENEM-CILASTATIN FOR EMPIRICAL THERAPY IN NEUTROPENIC PATIENTS WITH FEVER - AN OPEN STUDY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
HUIJGENS, PC
OSSENKOPPELE, GJ
WEIJERS, TF
VANLOENEN, AC
SIMOONSSMIT, AM
WIJERMANS, PW
VANPAMPUS, ECM
LANGENHUIJSEN, MMAC
EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 46 (01) : 42 - 46
[33] IMIPENEM COMPARED WITH CEFTAZIDIME PLUS VANCOMYCIN AS INITIAL THERAPY FOR FEVER IN NEUTROPENIC CHILDREN WITH CANCER
RIIKONEN, P
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (12) : 918 - 923
[34] Association between cytokine concentration kinetics and prolonged fever in febrile neutropenic children with bacteremia
Kim, Seong Koo
Han, Seung Beom
Kang, Jin Han
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
[35] Discontinuation of empirical antibiotic therapy in neutropenic acute myeloid leukaemia patients with fever of unknown origin: is it ethical?
Micol, J-B
Chahine, C.
Woerther, P-L
Ghez, D.
Netzer, F.
Dufour, C.
Merad, M.
Blot, F.
Chachaty, E.
de Botton, S.
Gachot, B.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (07) : O453 - O455
[36] Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study
de Pauw, BE
Sable, CA
Walsh, TJ
Lupinacci, RJ
Bourque, MR
Wise, BA
Nguyen, BY
DiNubile, MJ
Teppler, H
TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (01) : 31 - 37
[37] Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy
Schuler, Ulrich
Bammer, Susanne
Aulitzky, Walter E.
Binder, Claudia
Boehme, Angelika
Egerer, Gerlinde
Sandherr, Michael
Schwerdtfeger, Rainer
Silling, Gerda
Wandt, Hannes
Glasmacher, Axel
Ehninger, Gerhard
ONKOLOGIE, 2007, 30 (04): : 185 - 191
[38] Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis
van Rijn, Sander P.
Zuur, Marlanka A.
Anthony, Richard
Wilffert, Bob
van Altena, Richard
Akkerman, Onno W.
de Lange, Wiel C. M.
van der Werf, Tjip S.
Kosterink, Jos G. W.
Alffenaar, Jan-Willem C.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
[39] BACTEREMIA IN NEUTROPENIC CHILDREN
SIEGEL, JD
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (07) : 634 - 634
[40] Controversies in the management of fever in the neutropenic cancer patient
Seftel, Matthew D.
TRANSFUSION AND APHERESIS SCIENCE, 2010, 42 (02) : 151 - 156

← 1 2 3 4 5 →